Shaker Investments’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Shaker Investments’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-13,271	Closed	-$365K	–	97
2021 Q2	$365K	Sell	13,271 -22,188	-63%	-$436K	0.17%	80
2021 Q1	$585K	Buy	35,459 +12,589	+55%	+$287K	0.28%	69
2020 Q4	$421K	Buy	+22,870	New	+$409K	0.21%	71

Shaker Investments's TBIO Position: Q3 2021 in Review

Shaker Investments sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 13,271 shares — an estimated $365K sold.

Shaker Investments first reported a position in TBIO in Q4 2020 and held it in 3 quarters. The position peaked at $585K in Q1 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Shaker Investments reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Shaker Investments sold 13,271 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $365K.
Shaker Investments first reported a position in Translate Bio, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
Shaker Investments's Translate Bio, Inc. Common Stock position peaked at $585K in Q1 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Shaker Investments's 13F filing for Q3 2021, filed 8 Nov 2021.